(19)
(11) EP 1 373 485 A2

(12)

(88) Date of publication A3:
23.10.2003

(43) Date of publication:
02.01.2004 Bulletin 2004/01

(21) Application number: 02726212.0

(22) Date of filing: 26.03.2002
(51) International Patent Classification (IPC)7: C12N 9/12, C12N 15/12, C07K 14/705, C07K 14/47, G01N 33/50, C07K 16/18, C07K 16/28, C07K 16/40, A61K 39/00
(86) International application number:
PCT/EP2002/003393
(87) International publication number:
WO 2002/077216 (03.10.2002 Gazette 2002/40)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 27.03.2001 US 279188 P
19.04.2001 US 284987 P
04.06.2001 US 295726 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR LI 
  • Novartis Pharma GmbH
    1230 Wien (AT)

    AT 

(72) Inventors:
  • DE MARTIN, Rainer
    A-1120 Vienna (AT)
  • HOFER, Erhard
    A-1230 Vienna (AT)
  • HOFER-WARBINEK, Renate
    A-1238 Wien (AT)
  • KALTHOFF, Frank, Stephan
    A-2353 Guntramsdorf (AT)
  • LIPP, Hans-Joachim
    A-2500 Baden (AT)
  • MECHTCHERIAKOVA, Diana
    A-1130 Wien (AT)
  • SCHMID, Johannes
    A-2340 Mödling (AT)
  • SOBANOV, Yuri
    A-1050 Wien (AT)

(74) Representative: Grubb, Philip William 
Novartis AG,Corporate Intellectual Property
4002 Basel
4002 Basel (CH)

   


(54) IKK2 VARIANT, DINO GENE, LECTIN-LIKE RECEPTOR GENE, AND PROTEINS ENCODED THEREBY